Fact CheckerSign in

NCT07724093Not yet recruiting

Effects of Powered Hip Flexion Device in Persons With Multiple Sclerosis

The Effects of a Powered Hip Flexion Orthosis on Gait in Persons With Multiple Sclerosis: a Case Series

Source: ClinicalTrials.gov · Last updated 23 Jul 2026

Brief summary (registry, in English)

The purpose of this study is to assess the immediate effects of a commercially available non-FDA regulated powered hip flexion assist device (Hypershell X, Shenzhen, China) on walking ability in persons with MS. The main question it aims to answer is: Does a powered hip flexion device provide immediate improvements in walking ability over short distances for people with MS?

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
14 Jul 2026
Start date
15 Jul 2026
Primary completion date
1 May 2027
Lead sponsor
University of Dayton
NCT number
NCT07724093

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From 15 Jul 2026 to the primary completion date, 1 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior regular use of a hip flexion orthosis within the past 6 months.

Other illness

  • Any other neurological conditions that may affect gait.

Other

  • Cognitive or communication deficits that would limit ability to participate safely.
  • Significant pain or deformity of the lower extremities that could impact walking ability.
  • Severe spasticity (Modified Ashworth Score of 3 or 4) of the hips or lower extremities that could impact walking ability.

Who the study is looking for

  • Age 18-80
  • Diagnosis of relapsing remitting, primary progressive or secondary progressive MS
  • Unilateral or bilateral hip flexion weakness (Manual muscle testing score of 3 or less)
  • Ability to walk at least 30 meters without requiring rest and without physical support or assistance from another person.
  • Waist circumference 26-48", Height 5 '- 6'2", Weight 100-230lbs

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Dayton
Coordinator of this site? Confirm its status
DaytonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.